gvtcx

NHS National Pharmaceuticals Transition 2021_2 - Pemetrexed LSNE

NHS England Published 14 Jul 2021 Contracts Finder

key details

Value£1,520
Statuscomplete
Category (CPV) 33600000
Deadline26 May 2021
Contract start24 Jun 2021
Contract end31 Jan 2023
Procedureopen
SME suitableYes
OCIDocds-b5fd17-50f66811-fc34-4a5c-a6ba-6d48c9386892

Award

SupplierValueDateStatus
Mylan £1,520 16 Jun 2021 active

description

Offer reference number: CM/PHG/21/5639/00

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 38 months (19 months plus options to extend (at the Authority's sole discretion) for up to a further 19 months)

Potential periods of call-offs under the framework agreement:

24/06/2021 to 31/01/2023 (19 months) LSNE region.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
27 Apr 2021 Tender (tender) · f3c0ea90-72b6-4a35-9dea-ed60bb4a5afd-431923
14 Jul 2021 Award (award) · 91f4ed0b-4e63-4d29-9f3b-dcafca78bdf8-451329

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.